相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases
Qichun Wei et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer
A. Goncalves et al.
GYNECOLOGIC ONCOLOGY (2008)
Chemotherapy for recurrent, metastatic, or persistent cervical cancer: a systematic review
H. W. Hirte et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy
J. Souglakos et al.
ANNALS OF ONCOLOGY (2007)
Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer
Nasser Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: Morbidity and outcome: Results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer)
J. M. Classe et al.
GYNECOLOGIC ONCOLOGY (2006)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: A gynecologic oncology group study
HJ Long et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays
JY Kim et al.
GYNECOLOGIC ONCOLOGY (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis
CM Lee et al.
GYNECOLOGIC ONCOLOGY (2004)
Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01
PJ Eifel et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: A potential predictor of poor survival
GE Kim et al.
CLINICAL CANCER RESEARCH (2004)
HER2 expression in cervical cancer as a potential therapeutic target -: art. no. 59
A Chavez-Blanco et al.
BMC CANCER (2004)
P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma
NH Cho et al.
GYNECOLOGIC ONCOLOGY (2003)
Modern management of locally advanced cervical carcinoma
A Dueñas-Gonzalez et al.
CANCER TREATMENT REVIEWS (2003)
Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy
DK Gaffney et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Tumour therapy with radionuclides: assessment of progress and problems
J Carlsson et al.
RADIOTHERAPY AND ONCOLOGY (2003)
Current perspectives on HER2 testing:: A review of national testing guidelines
M Bilous et al.
MODERN PATHOLOGY (2003)
Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy
Y Niibe et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2003)
Expression of vascular endothelial growth factor in adenocarcinomas of the uterine cervix and its relation to angiogenesis and p53 and c-erbB-2 protein expression
JS Lee et al.
GYNECOLOGIC ONCOLOGY (2002)
Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis
JA Green et al.
LANCET (2001)
分享论文
